Moderna vaccine 'stable' at 2-8 degrees C for 30 days

Moderna's COVID-19 Vaccine Found 94.5% Effective | IE

Moderna's COVID-19 Vaccine Found 94.5% Effective | IE

USA biotech company Moderna on Monday announced a potential Covid-19 vaccine, which has been shown to be 94.5 per cent effective at protecting people from coronavirus, according to interim results from late-stage clinical trials.

Pfizer and Moderna's vaccines use the messenger RNA platform, Johnson and Johnson and AstraZeneca in partnership with Oxford University are on the live vector path while Novavax and Sanofi/ GlaxoSmithKline are building out their vaccine candidates on the recombinant protein platform.

"Last week, BioNTech and co-developers Pfizer said the preliminary analysis showed their vaccine could prevent more than 90% of people from getting Covid-19".

Moderna has joined Pfizer announcing solid progress in COVID-19 vaccine tests.

Moderna says studies are ongoing and more information is incoming.

The UK is expected to get 10 million doses of the BioNTech/Pfizer vaccine by the end of the year, with a further 30 million doses already ordered.

Trial ordered for accused gun supplier in Kenosha killings
Rittenhouse is charged with first-degree intentional homicide, which could land him in prison for life, if convicted. He told the newspaper that he was carrying the gun that night to protect himself.

Of the 95, 90 had been in the trial's placebo group, and five in the group that received the drug, called mRNA-1273.

The vaccine was well tolerated, with the majority of side-effects classed as mild or moderate.

"This news from Moderna is tremendously exciting and considerably boosts optimism that we will have a choice of good vaccines in the next few months", said Peter Openshaw, a professor of experimental medicine at Imperial College London.

New York, Nov 16 (IANS) Moderna's Covid vaccine, which has shown 94 per cent efficacy, "remains stable at 2 to 8 degrees C (36 to 46 degrees F), the temperature of a standard home or medical refrigerator, for 30 days, the company said on Monday, sending waves of relief through the medical community".

Pfizer's vaccine, on the other hand, needs to be stored in deep-freezer conditions which could complicate supply chain logistics, particularly in less developed countries. This allows longer shelf life and easier transportation of the vaccine.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.